Agnirva Space Premier League - Expedition #30516: Mission 4 on the ISS: Advancing Neuroimmune Research with 3D Microglia Models
- Agnirva.com

- Jul 31, 2025
- 2 min read
Mission 4 continues the pivotal exploration of how microgravity affects microglia—the brain’s immune cells—within 3D models of Parkinson’s Disease (PD) and Multiple Sclerosis (MS). With the National Stem Cell Foundation and Axiom Space at the helm, this phase builds upon insights gained in earlier missions and moves closer to uncovering new strategies to combat neurodegenerative diseases.
In microgravity, microglia exhibit different morphology and behavior compared to Earth-bound cells. This can offer vital clues into why and how these cells become destructive in diseases like PD and MS. Mission 4 intensifies this inquiry by using refined 3D cultures—more complex, more biomimetic, and more detailed than ever before.
What sets Mission 4 apart is the inclusion of patient-derived microglial cells and high-resolution time-lapse imaging. This allows scientists to track cellular transformations over time, potentially identifying early signs of neuroinflammation before symptoms manifest. The goal is to capture not just a snapshot but a full narrative of microglial response in a disease setting.
Findings from this mission will feed directly into the development of new therapies. If microgravity can influence microglial behavior to become less inflammatory or more supportive of neural repair, similar conditions might be mimicked on Earth through pharmaceuticals or biomedical engineering.
In sum, Mission 4 is a leap forward in precision medicine, leveraging space’s unique conditions to decode complex neurological illnesses. It symbolizes the promise of using off-Earth labs to heal conditions rooted deep within the human brain.
Join the Agnirva Space Internship Program




Comments